Drug application
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) (AMOXICILLIN, CLARITHROMYCIN, LANSOPRAZOLE)
Drugs@FDA ANDA 202588 · SANDOZ
Key facts
| Drug name | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) |
|---|---|
| Active ingredients | AMOXICILLIN, CLARITHROMYCIN, LANSOPRAZOLE |
| Application type | ANDA |
| Application number | 202588 |
| Company | SANDOZ |
| Dosage forms | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, ORAL |
| Strength | 500MG;500MG;30MG |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Mar 4, 2014 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.